InvestorsHub Logo
Followers 34
Posts 6200
Boards Moderated 0
Alias Born 07/05/2004

Re: None

Thursday, 03/26/2020 8:26:43 AM

Thursday, March 26, 2020 8:26:43 AM

Post# of 12443
Our advantage over many biotechs is that our monthly burn rate is next to nothing..the only impact I see is maybe a short delay in recruiting patients for the continuation of our phase 1b islet transplant trial for diabetes treatment ...but that wasn't going to start for a few months anyway...

At the moment most of what we are doing is documentation/paperwork and that will continue since many people are working from home.

Low burn rate is key..